Diageo plc & Reckitt Benckiser Group Plc Prove Why They Are Core Holdings For Investors

Diageo plc (LON: DGE) and Reckitt Benckiser Group Plc (LON: RB) are powering ahead despite economic woes.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Consumer giants Diageo (LSE: DGE) and Reckitt Benckiser (LSE: RB) are great additions to any portfolio. The two companies have proved this fact over the past few days. 

Indeed, this week Reckitt and Diageo have released first-half figures that beat City expectations. 

Diageo’s first-half numbers were released today. The company reported pre-tax profits of £2.9bn, which beat expectations and ended two years of declining profits for the group. However, organic sales fell 1% during the period. 

Nevertheless, including the contribution from United Spirits revenue increased 5% during the first half of 2015. Basic earnings per share increased 6%, and free cash flow — a crucial measure of business performance — grew by 54% to £2bn. 

Underlying figures 

Diageo’s performance during the first-half is mildly disappointing. While profits jumped, the group’s lacklustre sales growth took a shine off the results. 

That being said, it’s difficult for me to describe a company that’s growing profits and generating billions in cash as “struggling”. In fact, Diageo is preparing to embark on a growth trajectory over the next few years, and it has spent the two years preparing the foundations for growth. 

Over the past two years Diago has cut costs, streamlined its supply chain, sold off non-core assets and acquired new brands for its beverage portfolio. 

After these changes, management expects Diageo’s top line to begin expanding again during 2017. The company’s operating profit margin increased by 0.24% year on year during the first half of this year, and further margin growth is expected going forwards.  From 2017 onwards, the group is planning to unlock another £500m from cost savings to reinvest in the business. 

So, when Diageo’s sales do return to growth, the company’s earnings should charge higher as changes made over the past three years pay off. City analysts are expecting earnings growth of 7% next year. Diageo currently trades a forward P/E of 19.6 and supports a dividend yield of 3.1%. 

Boring but upbeat 

Reckitt released its first-half results at the beginning of this week, and the company surprised the City with numbers that beat even its own expectations. 

Reckitt’s net profit jumped by 10% during the first half as its three-year cost cutting programme reaped rewards. And just like Diageo, Reckitt now has a strong base from which to grow. While the group’s legacy business ticks along, management is now on the hunt for large acquisitions to complement Reckitt’s healthcare offering. 

Last year the company was outbid for Merck’s $14.2bn consumer health business, which sells items such as hayfever remedies. Still, the size of the deal with Merck Reckitt was chasing shows how aggressive the company is being. Taking on a $14.2bn deal would transform Reckitt’s product portfolio and catapult sales higher.

As Reckitt’s net debt to equity ratio is only 30%, the company certainly has room on its balance sheet to take on extra debt for acquisitions. The market seems to believe that Reckitt will strike a deal sometime soon. The company trades at a forward P/E of 25, a premium valuation that implies rapid earnings growth is just around the corner. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Why I’ve just sold two of the largest investments in my Stocks and Shares ISA

Stephen Wright has been making room for a new addition to his Stocks and Shares ISA. What is it and…

Read more »

Investing Articles

2 UK shares I’m avoiding like the plague in today’s stock market

Stephen Wright is a big fan of UK shares. But both the FTSE 100 and the FTSE 250 contain companies…

Read more »

Investing Articles

With yields over 8.8%, which of the FTSE 100’s top 5 passive income stocks do I think is the best?

These five passive income stocks are all yielding more than 8.8%. Our writer considers which of them (if any) would…

Read more »

Investing Articles

At 538p, is the Rolls-Royce share price really that expensive?

The Rolls-Royce share price has continued its incredible post-pandemic rally causing many to ask whether the stock’s overvalued. Our writer…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

The best investment quote of all time didn’t come from Warren Buffett!

Warren Buffett’s pithy quotes are both relevant and insightful. But the American billionaire didn’t come up with our writer’s favourite.

Read more »

Investing Articles

Down 13.7% in 7 days, what’s going on with the Lloyds share price?

Our writer looks at recent movements in the Lloyds share price. And asks whether now could be a good time…

Read more »

Dividend Shares

Here’s a simple 5-stock dividend income portfolio with a 7.5% yield

With these five British dividend stocks, one could potentially generate income of around £750 per year from a £10,000 investment.

Read more »

Investing Articles

If I’d put £10,000 into the FTSE 100’s biggest stock at the start of 2024, here’s what I’d have now

The FTSE 100’s biggest company has romped away from the index over the last five years, but has fallen behind…

Read more »